Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C

doi:10.3748/wjg.v13.i46.6236

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 46

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2068)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

196

HTML

1564

Figures (1-2)

169

Tables (1-5)

139

Sum=2068

Dec 14, 2007 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Dec 14, 2007; 13(46): 6236-6242
Published online Dec 14, 2007. doi: 10.3748/wjg.v13.i46.6236

Full Size Figure Download Figure

Figure 2 PePHD sequences (659-670) of HCV in complete response group (n = 21) and no-response group (n = 29). Dashes indicate the amino acid residues identical to the sequences on the top in each panel.

Citation: Yoon J, Lee JI, Baik SK, Lee KH, Sohn JH, Lee HW, Namkung J, Chang SJ, Choi JW, Kim HW, Yeh BI. Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C. World J Gastroenterol 2007; 13(46): 6236-6242
URL: https://www.wjgnet.com/1007-9327/full/v13/i46/6236.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i46.6236